{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:10:49Z","timestamp":1778717449888,"version":"3.51.4"},"reference-count":26,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2013,10,30]]},"published-print":{"date-parts":[[2014,5]]},"abstract":"<jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Assessment of peripheral blood tumour burden for staging of cutaneous T cells lymphoma is most often accomplished by flow cytometry (FC) using various non-standarised strategies. We report the results of calculating absolute Sezary cell counts (SCCs) by FC, based on the identification of aberrant T cell clusters on a virtual 6-dimensional space and independently of the expected immunophenotype (6D-FC SCC).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>6D-FC SCCs were calculated on 65 peripheral blood specimens from 28 patients with erythrodermic cutaneous T cells lymphoma (stage III or IV). Comparisons were made with recommended FC strategies and correlations with overall mortality were studied.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>At first visit, 17 of 28 patients (61%) had 6D-FC SCCs meeting current criteria for Stage IV disease (\u22651000\u2005SC\/\u03bcL); while only 2 patients (7%) met Stage IV criteria on other tissues. As defined by comprehensive staging using clinicomorphological criteria and 6D-FC SCCs, Stage IV disease identified a subgroup of patients with worse overall survival (p=0.0227). Residual non-aberrant CD4 T cells were markedly decreased in Stage IV disease (p=0.018). Among 65 specimens, discrepancies were observed between 6D-FC SCCs and usual FC thresholds for Stage IV disease, namely a CD4:CD8 ratio \u226510:1 (9 discrepancies, 14%), and \u226540% aberrant CD4 T cells (4 discrepancies, 6%). Surprisingly, 8 cases (12%) from 6 patients exhibited two distinctively separate clusters of aberrant CD4 T cells with different CD7 and\/or CD26 expression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Visual 6-dimensional identification of aberrant T cell clusters by FC allows for the calculation of clinically significant SCCs. Simplified gating strategies and relative quantitative values might underestimate the immunophenotypical complexity of Sezary cells.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jclinpath-2013-201748","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T23:58:47Z","timestamp":1386374327000},"page":"431-436","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":23,"title":["Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma. Implications for staging and prognosis"],"prefix":"10.1136","volume":"67","author":[{"given":"Pedro","family":"Horna","sequence":"first","affiliation":[{"name":"Department of Dermatology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darcie M","family":"Deaver","sequence":"additional","affiliation":[{"name":"Department of Hematopathology and Labororatory Medicine, H. Lee Moffitt Cancer Center, Tampa, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dahui","family":"Qin","sequence":"additional","affiliation":[{"name":"Depatmentment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn C","family":"Moscinski","sequence":"additional","affiliation":[{"name":"Department of Hematopathology and Labororatory Medicine, H. Lee Moffitt Cancer Center, Tampa, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo M","family":"Sotomayor","sequence":"additional","affiliation":[{"name":"Department of Hematopathology and Labororatory Medicine, H. Lee Moffitt Cancer Center, Tampa, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L Frank","family":"Glass","sequence":"additional","affiliation":[{"name":"Depatmentment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubomir","family":"Sokol","sequence":"additional","affiliation":[{"name":"Depatmentment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,12,6]]},"reference":[{"key":"2025092503502251000_67.5.431.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3502"},{"key":"2025092503502251000_67.5.431.2","unstructured":"Swerdlow SH Campo E Lee Harris N . WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC, 2008."},{"key":"2025092503502251000_67.5.431.3","first-page":"95","article-title":"Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas","volume":"46","author":"Vonderheid","year":"2002","journal-title":"JAMA"},{"key":"2025092503502251000_67.5.431.4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-055749"},{"key":"2025092503502251000_67.5.431.5","doi-asserted-by":"publisher","DOI":"10.1080\/10428190600709655"},{"key":"2025092503502251000_67.5.431.6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood.V66.2.358.358","article-title":"Diagnostic and prognostic significance of Sezary cells in peripheral blood smears from patients with cutaneous T cell lymphoma","volume":"66","author":"Vonderheid","year":"1985","journal-title":"Blood"},{"key":"2025092503502251000_67.5.431.7","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.7.857"},{"key":"2025092503502251000_67.5.431.8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.3.624"},{"key":"2025092503502251000_67.5.431.9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/ajcp\/106.6.739","article-title":"Immunophenotypic identification of Sezary cells in peripheral blood","volume":"106","author":"Bogen","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"2025092503502251000_67.5.431.10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.11.5954"},{"key":"2025092503502251000_67.5.431.11","first-page":"404","article-title":"Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses","volume":"35","author":"Harmon","year":"1996","journal-title":"JAMA"},{"key":"2025092503502251000_67.5.431.12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04014.x"},{"key":"2025092503502251000_67.5.431.13","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP09OTJOYAVZZK"},{"key":"2025092503502251000_67.5.431.14","doi-asserted-by":"publisher","DOI":"10.1309\/U1Y6-J4AG-5M4M-7AYV"},{"key":"2025092503502251000_67.5.431.15","doi-asserted-by":"publisher","DOI":"10.1309\/05GFG3LY3VYCDMEY"},{"key":"2025092503502251000_67.5.431.16","first-page":"499","article-title":"An Italian national multicenter study for the definition of reference ranges for normal values of peripheral blood lymphocyte subsets in healthy adults","volume":"84","author":"Santagostino","year":"1999","journal-title":"Haematologica"},{"key":"2025092503502251000_67.5.431.17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/cdli.3.3.326-330.1996","article-title":"Lymphocyte subpopulation reference ranges for monitoring human immunodeficiency virus-infected Chinese adults","volume":"3","author":"Kam","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"2025092503502251000_67.5.431.18","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.175"},{"key":"2025092503502251000_67.5.431.19","doi-asserted-by":"publisher","DOI":"10.1309\/25E9Y7RRAY84HTAT"},{"key":"2025092503502251000_67.5.431.20","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP7QHH5XASTJPL"},{"key":"2025092503502251000_67.5.431.21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.7665"},{"key":"2025092503502251000_67.5.431.22","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2365"},{"key":"2025092503502251000_67.5.431.23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480100060031"},{"key":"2025092503502251000_67.5.431.24","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1994.01690020064010"},{"key":"2025092503502251000_67.5.431.25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1044"},{"key":"2025092503502251000_67.5.431.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2001.tb11358.x"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2013-201748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:50:29Z","timestamp":1758797429000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2013-201748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,6]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,4,12]]},"published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1136\/jclinpath-2013-201748"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2013-201748","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,6]]}}}